Licensee Ownership. Licensor acknowledges that, as between Licensor and Licensee, Licensee is the owner of all right, title and interest, including intellectual property rights, in, to and under any and all Improvements to the Licensed Software created by or on behalf of Licensee (including by Licensor pursuant to Section 2.8) (collectively, “Licensee Improvements”), regardless of any technical, programming or financial assistance or cooperation provided to Licensee by or on behalf of Licensor to facilitate the operation and maintenance of the Licensee Improvements or the correction of any Defects thereto but subject, in all respects, to Licensor’s rights in the Licensed Software. Licensor hereby assigns all right, title and interest, including all intellectual property rights that Licensor may have or acquire in and to the Licensee Improvements to Licensee. Licensor shall, upon the reasonable request by, and at the cost of, Licensee, take further actions and execute additional documents to establish and perfect Licensee’s ownership rights in, to and under the Licensee Improvements.
Licensee Ownership. Licensee shall own any and all Intellectual Property and improvements and modifications of the Licensor IP relating to the Pharmaceutical Business developed or acquired on or after April 19, 2015 (i) solely by Licensee, or (ii) jointly or collaboratively with Licensee anywhere in the world (collectively, the “New IP”), except to the extent such New IP is owned by the Pharmaceutical Affiliate, and is subject to that certain License Agreement of even date herewith between Licensor and the Pharmaceutical Affiliate (the “Affiliate Pharmaceutical License Agreement”). The New IP shall be used and/or licensed to third parties by Licensee solely within the Territory and solely in connection with the Pharmaceutical Business; however, the use of the New IP by (a) the Pharmaceutical Affiliate outside of the Territory for its Pharmaceutical Business, pursuant and subject to the Affiliate Pharmaceutical License Agreement; and (b) Tikun Olam LLC, a Delaware company, which is also an Affiliate of Licensee (hereinafter “TO LLC”), within the Territory pursuant to the License Agreement dated April 20, 2016, between Licensor and TO LLC (the “US Medical Cannabis License Agreement”), shall be permitted and shall not be a breach of this Agreement.
Licensee Ownership. Following the IND Transfer Date, Licensee or its relevant Affiliates will have the sole right to file and hold all Regulatory Materials (including any Assigned Regulatory Materials) for the Licensed Compounds and Licensed Products in the Field in the Licensee Territory.
Licensee Ownership. Licensee will retain all right, title and interest in and to the products it develops using the Licensed Products.
Licensee Ownership. Licensor shall not acquire any right, interest, or title to the Licensee Technology or any derivative works thereof (as defined in the Copyright Law) through the exercise of any rights granted to Licensor hereunder. As between Licensee and Licensor, Licensee shall be considered the creator of the Licensee Technology and such derivative works, and all rights in the Licensee Technology and such derivative works, including without limitation the copyrights in and to the Licensee Technology and such derivative works, shall be the property of Licensee. In addition, Licensor hereby grants, assigns and conveys to Licensee any and all rights Licensor may now have or may be deemed to have in the future with respect to the Licensee Technology and such derivative works, including without limitation, any copyright to the Licensee Technology and such derivative works, or any portion thereof.
Licensee Ownership. Licensee shall have all right, title and interest (including all patent rights, copyrights, trade secret rights, and other intellectual property or proprietary rights throughout the world (collectively referred to as "Licensee's Rights")) in (a) its Confidential Information, (b) the Application Suite (including the perpetual License to the Licensed Software for the Clickstream Market as provided in Section 2.1) and (c) modifications, enhancements, improvements or new versions of the Licensed Software and the Application Suite created by Licensee or its contractors or created by Red Brick as Custom Code for Licensee under the Consulting Agreement. At Licensee's sole discretion, Red Brick may negotiate a license to use (but not sublicense) for use solely outside the Clickstream Market except as otherwise agreed by Licensee explicitly and in writing such modifications of the Licensed Software by Licensee or its contractors or created by Red Brick as Custom Code for Licensee under the Consulting Agreement.
Licensee Ownership. Licensee will own all of the right, title and interest (including patents, copyrights, trade secrets and any other intellectual property rights) in and to the results of the collaboration between the parties that are created solely by Licensee employees or agents.
Licensee Ownership. Subject to clause 8.1, the Licensee owns all rights, title and interest (including Intellectual Property Rights) in any and all improvements to any Intellectual Property (including the Medicinal IP) made or developed by the Licensee from the date of creation.
Licensee Ownership. Licensee retains all rights in and related to the Licensee’s personal information.
Licensee Ownership. Licensee retains ownership of student education records stored within Infinite Campus Products. These records are property of, and under the control of the Licensee. Licensee must obtain all necessary licenses and approvals before uploading any content and is solely responsible and liable for all Licensee content stored within the Infinite Campus Products.
